Co-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancers
Author:
Affiliation:
1. Department of Biotechnology and Pharmaceutical Engineering
2. Faculty of Chemical Engineering
3. School of Engineering
4. University of Tehran
5. Iran
6. Department of Life Science Engineering
7. Faculty of New Sciences & Technologies
Abstract
Simultaneous prolonged delivery of therapeutic gene, hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive LipoNiosome has been considered as a novel and promising method in order to treatment multi-drug resistant cancer.
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2017/RA/C7RA01736G
Reference40 articles.
1. Global cancer statistics, 2012
2. Columbamine suppresses the proliferation and neovascularization of metastatic osteosarcoma U2OS cells with low cytotoxicity
3. Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
4. Recent developments in the co-delivery of siRNA and small molecule anticancer drugs for cancer treatment
Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Composition, preparation methods, and applications of nanoniosomes as codelivery systems: a review of emerging therapies with emphasis on cancer;Nanoscale;2024
2. Nano vs Resistant Tuberculosis: Taking the Lung Route;AAPS PharmSciTech;2023-12-04
3. Current advances in niosomes applications for drug delivery and cancer treatment;Materials Today Bio;2023-12
4. Co-encapsulation of hydrophilic and hydrophobic drugs into niosomal nanocarrier for enhanced breast cancer therapy: In silico and in vitro studies;Environmental Research;2023-12
5. Prospects of new targeted nanotherapy combining liponiosomes with berberine to combat colorectal cancer development: An in vivo experimental model;International Journal of Pharmaceutics;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3